Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2026 on Thursday, ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today extended its ...

Affirm Holdings, Inc. today announced it will publish its third quarter fiscal year 2026 shareholder letter, including its financial results, on its investor relations website at on Thursday, May 7, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Arcosa, Inc. ("Arcosa" or the "Company"), a provider of infrastructure-related products and solutions, today announced that it will release results for the first quarter ended March 31, 2026 after ...

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Value Fund”. A copy of the letter can be downloaded here. The Fund seeks to ...

According to MarketsandMarkets™, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 ...

According to MarketsandMarkets, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 to USD 5.93 billion ...

Submitted GraftAssureDx™ for kidney transplant rejection testing for FDA review on Wednesday, March 25Welcomed second favorable head-to-head data set from an independent study at large hospital ...

Bio-Rad Laboratories has broadened its portfolio of recombinant monoclonal antibodies used in bioanalysis and drug monitoring ...